Overall, the review indicates that, while COCs effectively manage hyperandrogenism, insulin-sensitizing agents - particularly in combination - offer superior metabolic and long-term reproductive benefits in adolescents with PCOS [17]. This evidence concerns the gene INS and hyperandrogenism.